Superstring Capital Management LP
Superstring Capital Management LP reported 32 holdings worth US$158M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Superstring Capital Management LP reported 32 holdings worth US$158M as of Jun 30, 2026. Largest: Cogent Biosciences, Inc., Axsome Therapeutics, Inc. and Genmab A/s. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 32
- Value as reported
- US$158M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Cogent Biosciences, Inc. | 343K | US$13.3M | 8.4% |
| Axsome Therapeutics, Inc. | 53,916 | US$13.2M | 8.3% |
| Genmab A/s | 431K | US$11.8M | 7.5% |
| Celldex Therapeutics, Inc. | 288K | US$10.7M | 6.8% |
| Trevi Therapeutics, Inc. | 524K | US$9.78M | 6.2% |
| Revolution Medicines, Inc. | 51,053 | US$9.56M | 6.0% |
| Definium Therapeutics, Inc. | 188K | US$8.86M | 5.6% |
| Vir Biotechnology, Inc. | 854K | US$8.7M | 5.5% |
| Immunovant, Inc. | 208K | US$8.03M | 5.1% |
| Climb Bio, Inc. | 521K | US$6.79M | 4.3% |
| Savara, Inc. | 977K | US$6.02M | 3.8% |
| Maplight Therapeutics, Inc. | 125K | US$4.5M | 2.8% |
| Oric Pharmaceuticals, Inc. | 406K | US$4.4M | 2.8% |
| United Therapeutics Corporation | 7,172 | US$3.89M | 2.5% |
| Vaxcyte, Inc. | 66,793 | US$3.88M | 2.5% |
| Beone Medicines Ltd. Class A | 12,273 | US$3.5M | 2.2% |
| Cabaletta Bio, Inc. | 1.28M | US$3.48M | 2.2% |
| Zai Lab Ltd. | 156K | US$2.96M | 1.9% |
| Sionna Therapeutics, Inc. | 63,156 | US$2.78M | 1.8% |
| Bright Minds Biosciences Inc. | 30,456 | US$2.14M | 1.3% |
| Aclaris Therapeutics, Inc. | 258K | US$1.36M | 0.86% |
| Cybin, Inc. | 204K | US$1.35M | 0.85% |
| Roivant Sciences Ltd. | 25,623 | US$907K | 0.57% |
| Tonix Pharmaceuticals Holding Corp. | 63,648 | US$812K | 0.51% |
| Protara Therapeutics, Inc. | 121K | US$464K | 0.29% |
| Sensei Biotherapeutics, Inc. | 14,175 | US$354K | 0.22% |
| Boundless Bio, Inc. | 55,356 | US$138K | 0.09% |
| Biomea Fusion, Inc. | 250K | US$85,306 | 0.05% |
| Vyne Therapeutics Inc. | 61,269 | US$39,868 | 0.03% |
| Summit Therapeutics Inc. | 0 | US$0 | 0.00% |
| Taysha Gene Therapies, Inc. | 0 | US$0 | 0.00% |
| Travere Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Vertex Pharmaceuticals Incorporated | 0 | US$0 | 0.00% |
| Arvinas, Inc. | 0 | US$0 | 0.00% |
| Century Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cullinan Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Iqvia Holdings, Inc. | 0 | US$0 | 0.00% |
| Oruka Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Palatin Technologies, Inc. | 0 | US$0 | 0.00% |
| Pfizer, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related